Tag: reaction

Slick City Action Park Names Josh Cole Chief Marketing Officer

Slick City names franchise marketing veteran Josh Cole as first CMO, tapping his growth expertise to accelerate expansion, support and brand awareness

DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with...

Châtillon, France, June 2, 2026

HelloNation Article Explains Protecting Eyes From Kentucky Allergies Featuring Optometry Expert Dr. Kimberly Arnett

The article clarifies how to distinguish allergy symptoms from infections and outlines steps to reduce irritation and protect eye health.FLORENCE, Ky., June 2, 2026...

Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026...

- The INDIGO study met its primary and all key secondary endpoints with statistically significant results -

Aurora World Inc. to Bring the Beloved Holiday Classic Rudolph the Red-Nosed Reindeer to Life in an Outstanding New Plush Collection

PICO RIVERA, Calif., June 2, 2026 /PRNewswire/ -- Aurora World Inc., a global leader in the plush toy market, is thrilled to announce an...

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

AQUIPTA® (atogepant) is now approved in the European Union for the acute treatment of migraine in adults, with or without aura, and for the...

Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

PAPZIMEOS approval marks a historic milestone for the RRP patient community as the first and only FDA-approved therapy for the treatment of adults with...

FLOWERS FOODS, INC. REPORTS SECOND QUARTER 2025 RESULTS

THOMASVILLE, Ga., Aug. 15, 2025 /PRNewswire/ -- Flowers Foods, Inc. (NYSE: FLO) today reported financial results for the company's 12-week second quarter ended July 12, 2025. ...

Trump’s AI Chipmaker Deal: Another Chapter in the Tech Delusion Chronicles

Ah, the spectacle of geopolitical chess, where the grandmasters wear suits and the pawns are cutting-edge semiconductors. Let’s dive into the latest episode of...

Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity

Greywolf starts first trial of GRWD0715, aiming for a functional cure for autoimmunity by targeting its antigenic source.

TennaVision: Cut the Cable and Enjoy Free HD TV with Our Digital Antenna in 2025

A 2025 over-the-air TV solution from Kozy that delivers free HD channels without monthly cable bills or complicated setup.

A 2025 over-the-air TV solution from Kozy that delivers free HD channels without monthly cable bills or complicated setup.

Performance Brokerage Services Advises on Sale of Dick Masheter Ford in Columbus, Ohio to Drive Choice

Performance Brokerage Services, the leader in dealership buy-sell activity, announces the sale of Dick Masheter Ford in Columbus, Ohio from Bob Masheter to Oleg Kislyansky...

Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition of UDENYCA®

AHMEDABAD, India, Aug. 7, 2025 /PRNewswire/ -- Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsReaction

FGR accelerates USA expansion & defence sector exposure with strategic acquisition of MITO® Material Solutions

Liftoff Announces Pricing of Initial Public Offering

Quantinuum Announces Pricing of Upsized Initial Public Offering